Nippon India Consumption Fund-IDCW Reinvestment
Nippon India Consumption Fund-IDCW Reinvestment: Mutual Fund Overview
Nippon India Consumption Fund-IDCW Reinvestment is an Thematic-Consumption mutual fund with over 21.45 years of performance history. The scheme manages an AUM of ₹2512.36 Cr and has a NAV of ₹31.7314. It is rated '4' stars by analysts. Investors can begin a SIP with as little as ₹100.0, making it accessible for all types of investors. In the last 1 year, the fund has delivered a return of -0.21%.
Equity, Thematic-Consumption, Principal at very high risk
1 Year Return -0.21% at 12 Mar 2026 07:06 PM
Fund Details
NAV 31.7314
Sub-Type Thematic-Consumption
Rating 4
Min. SIP Amount ₹100.0
Fund Age(Year) 21.45
Fund Size(in Crores) 2512.36
Fund Performance
1 Month -9.21%
3 Month -10.75%
6 Month -15.36%
1 Year -0.21%
3 Year 12.56%
5 Year 14.02%
Know This Fund
As on 12 Mar 2026
Investment strategy that balances risk & reward by dividing the investment portfolio among different types of asset classes.
Equity (98.21%) Market Cap Mid Cap 29.98 Large Cap 27.77 Small Cap 40.45 Top Sectors Healthcare 97.37 Services 0.84 Top Holding Divi's Laboratories 3.52 Ipca Laboratories 2.17 Laxmi Dental 0.26 Dr. Reddy's Laboratories 3.48 Acutaas Chemicals 1.07 Dr. Lal Pathlabs 1.26 Emcure Pharmaceuticals 0.94 Ajanta Pharma 7.04 Krishna Institute 1.55 Alkem Laboratories 3.47 Anthem Biosciences 1.91 Biocon 0.7 Orchid Pharma 0.56 Cipla 1.83 Alembic Pharmaceuticals 0.52 Metropolis Healthcare 1.66 Syngene International 0.69 Aurobindo Pharma 2.66 Glenmark Pharmaceuticals 4.25 Jupiter Life Line Hospitals 2.06 Procter & Gamble Health 2.21 Sanofi Consumer Healthcare India 0.98 Jubilant Pharmova 0.7 Apollo Hospitals Enterprise 3.75 Windlas Biotech 1.13 Sai Life Sciences 2.07 Pfizer 1.77 Sudeep Pharma 2.19 Fortis Healthcare 2.98 Global Health 2.02 Max Healthcare Institute 2.85 Sun Pharmaceutical Industries 9.42 Lupin 5.79 Rainbow Children's 0.85 Caplin Point Laboratories 2.23 Viyash Scientific 2.11 Aarti Pharmalabs 0.84 Eris Lifesciences 1.84 Vijaya Diagnostic Centre 1.09 Gland Pharma 3.54 Cohance Lifesciences 2.66 Marksans Pharma 1.65 Aster DM Healthcare 1.94
Debt & Others (1.8%) Sector Allocation CBLO 0.01 Net Current Assets 1.79 Debt Credit Ratings Debt Category Others 1.79
Comparison with same funds
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-Growth Ret 1M 1.98% Ret 1Y 11.98% Ret 3Y 24.68% Ret 5Y 14.39%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Ret 1M 1.98% Ret 1Y 11.98% Ret 3Y 24.68% Ret 5Y 14.39%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Reinvestment Ret 1M 1.98% Ret 1Y 11.98% Ret 3Y 24.68% Ret 5Y 14.39%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-Growth Ret 1M -0.57% Ret 1Y 8.51% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Payout Ret 1M -0.57% Ret 1Y 8.51% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Reinvestment Ret 1M -0.57% Ret 1Y 8.51% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan BSE Healthcare Index Fund Regular-Growth Ret 1M 1.7% Ret 1Y 11.07% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - Growth Ret 1M 1.28% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Ret 1M 1.28% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Reinvestment Ret 1M 1.28% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Baroda BNP Paribas Health and Wellness Fund Regular-Growth Ret 1M 1.41% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Charges & Taxes Expense Ratio
Returns are taxed as per your Income Tax Slab.
Expense Ratio (Inclusive of GST): 2.0%
Exit Load 0%
Stamp Duty 0.005%
Fund Management
The various expenses, charges and taxes associated with your Mutual Fund
Divya Dutt Sharma
Education Bachelor of Commerce, MSC Banking & Finance.
Experience Prior to joining the Nippon AMC, he was associated with Bhramrishi Mission NGO, Equations LLC, V.K Pamecha and Associates.
Amber Singhania
Education MMS Finance (Mumbai University)
Experience Prior to joining the Nippon India AMC, he was associated with Asian Markets Securities Pvt. Ltd.
Lokesh Maru
Education Bachelor of Technology, CFA, FRM
Experience Prior to joining the Nippon AMC, he was associated with BlackRock Services India Private Ltd, CRISIL Ltd.
Kinjal Desai
Education Ms. Desai has done B.A (Economics), MSc. (Economics) and has cleared CFA Level 1
Experience She has been working with Nippon India Mutual Fund since year, 2012
Amar Kalkundrikar
Education Mr. Kalkundrikar has done B.Com, CA, CFA, and MBA from Columbia Business School.
Experience Prior to joining HDFC Asset Management Company Limited, he has worked with Nippon India Mutual Fund, and HDFC AMC. He worked with multiple roles at HDFC MF.
Riskometer
Mutual Fund Investments are subject to market risk. Read all scheme related documents carefully.
Principal at very high risk
AMC and Fund details
Rank (total sets) 29
Date of Incorporation 2004-09-30
Total AUM 741773.83
The Scheme Seeks to generate returns from a portfolio of pure debt oriented funds accessed through the diverse investment styles of underlying schemes selected in accordance with the BSLAMC process.
Take Your Next Step
